PMID: 2482710Jul 1, 1989Paper

Critical evaluation of the in vivo selectivity between hypotensive and platelet antiaggregating actions of iloprost and prostacyclin in beagle dogs.

Archives Internationales De Pharmacodynamie Et De Thérapie
F HermánK Magyar

Abstract

We compared the hypotensive and antiaggregatory effects of PGI2 and iloprost using our computerized aggregometric system. The concentration producing 50% inhibition (IC50) of ADP-induced platelet aggregation in vitro was 0.35 +/- 0.15 nM for PGI2 and 0.56 +/- 0.2 nM for iloprost (n = 5). The in vivo antiaggregatory activity was measured with a modified filtration pressure technique in anaesthetized beagle dogs. PGI2 was equipotent with iloprost in inhibiting platelet aggregation in vivo (ED25 = 0.23 +/- 0.04 nmol/kg; 0.26 +/- 0.05 nmol/kg, respectively). At the same time, PGI2 was twice as potent as iloprost in decreasing the mean arterial blood pressure (ED25 = 0.41 +/- 0.12 nmol/kg; 0.82 +/- 0.17 nmol/kg, respectively). The antiaggregatory and hypotensive effects of iloprost lasted longer in each experiment than those of PGI2; this difference reached the level of significance in the highest bolus dose range. The in vivo selectivity ratios (hypotensive potency/antiaggregatory potency) of iloprost and PGI2 were 0.32 and 0.67, respectively. The results indicate that 1) in anaesthetized beagles iloprost is somewhat more selective than PGI2 in inhibiting platelet aggregation (p less than 0.05); 2) our aggregometric system might be...Continue Reading

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.